Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 14, 2024
Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
Yuanfang Li, Baiwei Zhao, Juzheng Peng, et al.
Frontiers in Immunology
|
August 7, 2024
Dynamics of peripheral blood inflammatory index predict tumor pathological response and survival among patients with locally advanced non-small cell lung cancer who underwent neoadjuvant immunochemotherapy: a multi-cohort retrospective study
Wenyu Zhai, Chao Zhang, Fangfang Duan, et al.
Eclinicalmedicine
|
April 24, 2026
Fraction dose escalation of split-course concurrent chemoradiotherapy following induction chemo-immunotherapy in unresectable locally advanced oesophageal squamous carcinoma in China (GASTO-10102): a single-centre phase 1 study
FangJie Liu, DaQuan Wang, GuangYu Luo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 14, 2026
Surgery after neoadjuvant immunochemotherapy versus immuno-chemoradiotherapy in patients with cN3 non-small cell lung cancer: A cohort study in two academic centers
Wenyu Zhai, Dachuan Liang, Xiangyang Yu, et al.
Planta Medica
|
June 11, 2016
Cytotoxic and Antitumor Effects of Curzerene from Curcuma longa
Youdi Wang, Jiahong Li, Jiquan Guo, et al.
The Lancet. Oncology
|
December 25, 2025
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
Chih-Hung Hsu, Zhihao Lu, Shegan Gao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 20, 2023
A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial
Tiantian Gao, Yong Yang, Zewei Zhang, et al.
Plos One
|
March 8, 2013
Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients
Yanan Kong, Junye Wang, Wanli Liu, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
March 27, 2021
Computed Tomography‒Guided Microwave Ablation Combined with Osteoplasty for the Treatment of Bone Metastases: A Multicenter Clinical Study
Xusheng Zhang, Xin Ye, Kaixian Zhang, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
June 2, 2022
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules
Yanzhen Lai, Yu Wang, Yaxian Wu, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 14, 2024
Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
Yuanfang Li, Baiwei Zhao, Juzheng Peng, et al.
Frontiers in Immunology
|
August 7, 2024
Dynamics of peripheral blood inflammatory index predict tumor pathological response and survival among patients with locally advanced non-small cell lung cancer who underwent neoadjuvant immunochemotherapy: a multi-cohort retrospective study
Wenyu Zhai, Chao Zhang, Fangfang Duan, et al.
Eclinicalmedicine
|
April 24, 2026
Fraction dose escalation of split-course concurrent chemoradiotherapy following induction chemo-immunotherapy in unresectable locally advanced oesophageal squamous carcinoma in China (GASTO-10102): a single-centre phase 1 study
FangJie Liu, DaQuan Wang, GuangYu Luo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 14, 2026
Surgery after neoadjuvant immunochemotherapy versus immuno-chemoradiotherapy in patients with cN3 non-small cell lung cancer: A cohort study in two academic centers
Wenyu Zhai, Dachuan Liang, Xiangyang Yu, et al.
Planta Medica
|
June 11, 2016
Cytotoxic and Antitumor Effects of Curzerene from Curcuma longa
Youdi Wang, Jiahong Li, Jiquan Guo, et al.
The Lancet. Oncology
|
December 25, 2025
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
Chih-Hung Hsu, Zhihao Lu, Shegan Gao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 20, 2023
A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial
Tiantian Gao, Yong Yang, Zewei Zhang, et al.
Plos One
|
March 8, 2013
Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients
Yanan Kong, Junye Wang, Wanli Liu, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
March 27, 2021
Computed Tomography‒Guided Microwave Ablation Combined with Osteoplasty for the Treatment of Bone Metastases: A Multicenter Clinical Study
Xusheng Zhang, Xin Ye, Kaixian Zhang, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
June 2, 2022
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules
Yanzhen Lai, Yu Wang, Yaxian Wu, et al.
Page
of 10